Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04794621 · ClinicalTrials.gov registry record · NA
Electroceutical Dressing Technology (EDT) Against Wound Microbial Biofilm Infection
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT04794621: Completed NA study, sponsored by Indiana University.
NCT04794621 is a NA study that has completed, run by Indiana University. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04794621, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
There are currently limited treatments available that show anti-biofilm efficacy for wound infection management Biofilms account for over 80% of infections and approximately 65% of nosocomial infections caused by microorganisms in the developed world involve biofilms. There clearly is a need for cost effective, highly stable, easily obtained biofilm targeted strategies for treatment of chronic wound biofilm infections. The information generated from this project has the potential of providing considerable benefits to wound care by determining the efficacy of EDT dressing in managing wound biofilm infection and efficacy in wound healing and closure. Such knowledge could help therapeutic strategies and could provide information for future clinical studies to further understanding -of EDT wound dressings.
Primary Outcome
Impact of EDT treatment in prevention of incidence of wound biofilm infection
Interventions
- DEVICE Electroceutical Dressing Technology-EDThi
- DEVICE Adding EDTlo (Procellera®) for 3 weeks after use of EDThi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2023-07-07 |
| Phase | NA |
What the finished NCT04794621 record still lists
NCT04794621 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Electroceutical Dressing Technology-EDThi is the first listed.
NCT04794621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04794621 about?
NCT04794621 is a clinical study titled "Electroceutical Dressing Technology (EDT) Against Wound Microbial Biofilm Infection". There are currently limited treatments available that show anti-biofilm efficacy for wound infection management Biofilms account for over 80% of infections and approximately 65% of nosocomial infections caused by microorganisms in the developed world involve biofilms. There clearly is a need for cos...
What is the current status of trial NCT04794621?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2021-06-03. Estimated completion is 2023-07-07.
What interventions are being tested in trial NCT04794621?
The interventions under investigation include: Electroceutical Dressing Technology-EDThi (DEVICE), Adding EDTlo (Procellera®) for 3 weeks after use of EDThi (DEVICE).
Who is sponsoring clinical trial NCT04794621?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04794621's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI